Breathe Well Live Well
|
Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11
StreetInsider.com “The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of asthma … |
View full post on asthma – Google News
Philadelphia Business Journal |
Asthma medicine approval is a local success story
Philadelphia Business Journal … Reporter Philadelphia Business Journal. Stephen Tullman, managing partner of NeXeption. Enlarge. Stephen Tullman, managing partner of NeXeption. Jeff Fusco. FDA approval for the asthma drug Cinqair illustrates the benefits of one deal that got done. |
View full post on asthma – Google News
Lung Disease News |
Glaxo's asthma drug Nucala gets Japanese approval
MarketWatch The Japanese Ministry of Health, Labour and Welfare granted approval for the drug "as a treatment for bronchial asthma in patients with refractory asthma whose symptoms are inadequately controlled with standard treatment," Glaxo said Tuesday. FDA Approves Teva's Asthma Drug Cinqair as Add-on Treatment GSK: Nucala Receives Approval In Japan For Treatment Of Bronchial Asthma Nucala and Cinqair for the Treatment of Severe Asthma |
View full post on asthma – Google News
Danbury News Times |
Boehringer Ingelheim's asthma drug wins FDA approval
Danbury News Times DANBURY — Nearly one in 10 adults in Connecticut – 9.2 percent – has asthma. Boehringer Ingelheim, the Danbury-based pharmaceutical company cited the figure as it announced the federally approved availability of its new Spiriva Respimat product for … Spiriva Respimat Now Available in Pharmacies for Asthma Patients |
View full post on asthma – Google News
|
FDA advisers recommend approval of asthma drug for adults
Pharmacy Today, American Pharmacists Association, pharmacist.com An FDA advisory committee has recommended the agency approve Teva Pharmaceutical's experimental drug reslizumab for severe asthma in patients aged 18 years and older. Reslizumab is an antibody drug designed to be given intravenously once every … |
View full post on asthma – Google News
Fox News |
FDA advisers recommend approval of Teva asthma drug in adults
Fox News An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's. The panel voted unanimously that the drug should not be approved for children aged 12 to 17. US FDA advisers recommend approval of Teva asthma drug for adults FDA Advisory Committee Recommends Approval of Teva's Asthma Biologic Reslizumab |
View full post on asthma – Google News
Reuters |
US FDA advisers recommend approval of Teva asthma drug for adults
Reuters An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's <TEVA.TA) experimental drug reslizumab for severe asthma in patients aged 18 and older. Ad Comm tomorrow for Teva's asthma candidate reslizumab |
View full post on asthma – Google News
BioPharma-Reporter.com |
GSK set to kickstart asthma mAb sector after EU Nucala approval
BioPharma-Reporter.com This decline, coupled with the underperformance of more recently launched drugs – Breo and Anoro Ellipta – saw revenue generated by GSK's asthma franchise fall 10% to £6.1bn in 2014. GSK has not given a forecast for Nucala, but clearly it hopes the … |
View full post on asthma – Google News
Telegraph.co.uk |
Cat allergy group Circassia wins approval for asthma drug
Telegraph.co.uk Cat allergy group Circassia wins approval for asthma drug. The inhaler will soon be available to European consumers as a generic alternative to rival a treatment already on the market from GlaxoSmithKline. Grumpycat. Circassia is developing a novel … Industry NewsCircassia wins EU asthma product approval Circassia wins EU regulatory boost for asthma generic drug Circassia Pharma gets UK approval for asthma challenger |
View full post on asthma – Google News
KRQE News 13 |
Glaxo wins US approval for drug to treat severe asthma
KRQE News 13 WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved an injectable drug from GlaxoSmithKline PLC to treat severe asthma attacks. The agency cleared Nucala for patients 12 years and older who cannot control their asthma with … |
View full post on asthma – Google News